World Circulating Tumor Cells Summit November 8, 2011

The 3rd World Circulating Tumor Cells (CTCs) Summit will focus on how the industry can practically apply CTCs in the clinic and realize their commercial potential. The event will highlight the application of CTCs as predictive biomarkers and non-invasive cancer diagnostics, as well as the technologies involved in achieving this.

Theresa LaValle will present “Analysis of CTCs: molecular characterization and potential applications in drug development.”